23:26

Key Insights in Lymphoma

HMP Education

18:17

New Targets in peripheral T cell lymphomas

HMP Education

24:44

Novel therapeutic strategies in B cell lymphomas

HMP Education

15:00

Debate: Hodgkin lymphoma patient who remains PET+ at the end of chemotherapy - Radiation therapy

HMP Education

13:16

Debate: Hodgkin lymphoma patient who remains PET+ at the end of chemotherapy - SCT-based therapy

HMP Education

12:11

Debate: Hodgkin lymphoma patient who relapses after autologous SCT - Serial novel agents

HMP Education

13:03

Debate: Hodgkin lymphoma patient who relapses after autologous SCT - Allogeneic SCT

HMP Education

22:57

How should we approach the adolescent/young adult Hodgkin lymphoma patient?

HMP Education

27:49

Hodgkin disease: The past, the present, and the future

HMP Education

20:11

Should we use cell of origin and "double protein" expression in treating DLBCL?

HMP Education

17:23

What's new in the approach to primary CNS lymphoma: Upfront and relapsed

HMP Education

27:10

What are the most promising new approaches and agents for T cell lymphoma?

HMP Education

15:41

Novel agents in follicular lymphoma

HMP Education

10:51

Debate: Relapsed 60 y/o Follicular lymphoma patient after upfront R-CHOP - SCT

HMP Education

18:48

Debate: Relapsed 60 y/o Follicular lymphoma patient after upfront R-CHOP - Novel agents

HMP Education

23:29

Strategies to focus on quality of life in choosing lymphoma therapy

HMP Education